Clinical trial

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

NCT00111228

Study summary

ClinicalTrials.gov

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention Guardian RT Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention SMBG only Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-10-01

PhaseNA

Conditions

Diabetes Mellitusverified · MONDO: diabetes mellitus

Interventions

Guardian RTDEVICE

SMBG onlyDEVICE

Sponsors & collaborators

Medtronic MiniMed, Inc.lead sponsor

Mapped research locations

ParisFrance1 BerlinGermany1 MilanItaly1 Petah TikvaIsrael1 LjubljanaSlovenia1 BournemouthUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00111228 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.